Comment on “Interpreting Clinical Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer (BRPC)”
2019 ◽
Vol 270
(2)
◽
pp. e48-e50
◽
Zachary R. McCaw
◽
Lu Tian
◽
Dae Hyun Kim
◽
Lee-Jen Wei
Zachary R. McCaw
◽
Lu Tian
◽
Dae Hyun Kim
◽
Lee-Jen Wei
2014 ◽
Vol 113
(1)
◽
pp. 41-46
◽
Jordan Kharofa
◽
Susan Tsai
◽
Tracy Kelly
◽
Clint Wood
◽
Ben George
◽
...
2018 ◽
Vol 210
(5)
◽
pp. 1059-1065
◽
Ijin Joo
◽
Jeong Min Lee
◽
Eun Sun Lee
◽
Su Joa Ahn
◽
Dong Ho Lee
◽
...
2018 ◽
Vol 268
(2)
◽
pp. 215-222
◽
Jin-Young Jang
◽
Youngmin Han
◽
Hongeun Lee
◽
Sun-Whe Kim
◽
Wooil Kwon
◽
...
2013 ◽
Vol 13
(4)
◽
pp. S36
Jin Ho Lee
◽
Chang Moo Kang
June S. Peng
◽
Gareth Morris-Stiff
◽
Noaman S. Ali
◽
Jane Wey
◽
Sricharan Chalikonda
◽
...
2015 ◽
Vol 94
(31)
◽
pp. e1233
◽
Jin Ho Lee
◽
Chang Moo Kang
◽
Seung Min Bang
◽
Jin Young Choi
◽
Jin Sil Seong
◽
...
2011 ◽
Vol 81
(2)
◽
pp. S335
D.M. Sopka
◽
Y.S. Chun
◽
S.J. Cohen
◽
F. Zhu
◽
B.N. Milestone
◽
...
2010 ◽
Vol 78
(3)
◽
pp. S320
C. Wood
◽
T. Kelly
◽
D. Prah
◽
P. Ritch
◽
D. Evans
◽
...
2013 ◽
Vol 2
(4)
◽
pp. 413-425
◽
Avani S. Dholakia
◽
Amy Hacker-Prietz
◽
Aaron T. Wild
◽
Siva P. Raman
◽
Laura D. Wood
◽
...
Close
Export Citation Format
Close
Share Document
Close